Literature DB >> 21597977

Infliximab-induced autoimmune hepatitis with successful switch to adalimumab in a patient with Crohn's disease: the index case.

Dahlia A Goldfeld1, Elizabeth C Verna, Jay Lefkowitch, Arun Swaminath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21597977     DOI： 10.1007/s10620-011-1748-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

Review 1.  Hepatotoxicity of agents used in the management of inflammatory bowel disease.

Authors:  Omar S Khokhar; James H Lewis
Journal:  Dig Dis       Date:  2010-09-30       Impact factor: 2.404

2.  Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.

Authors:  A Haennig; D Bonnet; S Thebault; L Alric
Journal:  Gastroenterol Clin Biol       Date:  2010-02-26

3.  Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis.

Authors:  Jeremy Sokolove; Vibeke Strand; Jeffrey D Greenberg; Jeffrey R Curtis; Arthur Kavanaugh; Joel M Kremer; Alina Anofrei; George Reed; Leonard Calabrese; Michele Hooper; Scott Baumgartner; Daniel E Furst
Journal:  Ann Rheum Dis       Date:  2010-05-06       Impact factor: 19.103

4.  Simplified criteria for the diagnosis of autoimmune hepatitis.

Authors:  Elke M Hennes; Mikio Zeniya; Albert J Czaja; Albert Parés; George N Dalekos; Edward L Krawitt; Paulo L Bittencourt; Gilda Porta; Kirsten M Boberg; Harald Hofer; Francesco B Bianchi; Minoru Shibata; Christoph Schramm; Barbara Eisenmann de Torres; Peter R Galle; Ian McFarlane; Hans-Peter Dienes; Ansgar W Lohse
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

Review 5.  Infliximab-related hepatitis: discussion of a case and review of the literature.

Authors:  Stefano Mancini; Elisa Amorotti; Sarah Vecchio; Maurizio Ponz de Leon; Luca Roncucci
Journal:  Intern Emerg Med       Date:  2010-01-27       Impact factor: 3.397
  5 in total
  14 in total

Review 1.  Autoimmune hepatitis: a review.

Authors:  Andrea A Gossard; Keith D Lindor
Journal:  J Gastroenterol       Date:  2012-04-17       Impact factor: 7.527

Review 2.  Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.

Authors:  A Grasland; R Sterpu; S Boussoukaya; I Mahe
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

3.  Severe cholestasis due to adalimumab in a Crohn's disease patient.

Authors:  Edward Kim; Brian Bressler; David F Schaeffer; Eric M Yoshida
Journal:  World J Hepatol       Date:  2013-10-27

Review 4.  Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.

Authors:  Ersilia M DeFilippis; Sonal Kumar
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

5.  Infliximab leading to autoimmune hepatitis: an increasingly recognized side effect.

Authors:  Bulent Yilmaz; Emir Charles Roach; Seyfettin Koklu
Journal:  Dig Dis Sci       Date:  2014-10       Impact factor: 3.199

Review 6.  Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.

Authors:  Roberta Elisa Rossi; Ioanna Parisi; Edward John Despott; Andrew Kenneth Burroughs; James O'Beirne; Dario Conte; Mark Ian Hamilton; Charles Daniel Murray
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

7.  Rituximab-induced autoimmune hepatitis: A case study and literature review.

Authors:  Polymnia Galiatsatos; Sarit Assouline; Adrian Gologan; Nir Hilzenrat
Journal:  Can Liver J       Date:  2020-11-17

Review 8.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors:  Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

Review 9.  Hepatic manifestations of non-steroidal inflammatory bowel disease therapy.

Authors:  Robert Hirten; Keith Sultan; Ashby Thomas; David E Bernstein
Journal:  World J Hepatol       Date:  2015-11-28

10.  Autoimmune Hepatitis Triggered by Anti-TNF-α Therapy.

Authors:  Satoshi Nakayama
Journal:  Case Rep Med       Date:  2013-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.